Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.17
-0.47-1.83%
Last update: Aug 17, 9:56 AM
Mineralys Therapeutics Inc (MLYS) Stock Price, Quote, News & History
MLYSNASDAQ
Earnings: Q2 2026 Earnings were released on Tue Aug 11th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 6 days agoClick to view the webcast
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mineralys Therapeutics (MLYS) stock?
You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.
Who are Mineralys Therapeutics (MLYS) competitors?
Other companies in Mineralys Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Mineralys Therapeutics (MLYS) stock?
Mineralys Therapeutics has a consensus price target of $48.67.
What is the current price for Mineralys Therapeutics (MLYS)?
The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $25.1701 last updated August 17, 2026 at 9:56 AM EDT.
Does Mineralys Therapeutics (MLYS) pay a dividend?
There are no upcoming dividends for Mineralys Therapeutics.
When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?
Mineralys Therapeutics does not have any upcoming earnings scheduled.
Is Mineralys Therapeutics (MLYS) going to split?
There is no upcoming split for Mineralys Therapeutics.
What sector and industry does Mineralys Therapeutics (MLYS) operate in?
Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
